Home Clinical Topics FDA approves expanded use of Prevnar vaccine

FDA approves expanded use of Prevnar vaccine

The U.S. Food and Drug Administration (FDA) has approved the use of Prevnar 13, a pneumococcal 13-valent conjugate vaccine, in people 50 years and older. Read More.

LEAVE A REPLY

Please enter your comment!
Please enter your name here